Company Filing History:
Years Active: 2018-2025
Title: Innovations of Xiangsheng Liu in Nanocarrier Technology
Introduction
Xiangsheng Liu is a prominent inventor based in Los Angeles, CA, known for his significant contributions to the field of nanocarrier technology. With a total of 6 patents, Liu has focused on developing advanced drug delivery systems that enhance the efficacy of pharmaceuticals.
Latest Patents
Liu's latest patents include groundbreaking work on the scale-up synthesis of silicasome nanocarriers. This innovation addresses the challenges of producing drug-loaded silicasomes in large quantities, which are essential for commercial applications. His research revealed that traditional laboratory synthesis methods do not translate effectively to large-scale production, resulting in heterogeneous products unsuitable for pharmaceutical use. To overcome this, Liu developed new methods that enable the large-scale production of mesoporous silica nanoparticles (MSNPs) and lipid bilayer coated MSNPs, known as silicasomes.
Another notable patent involves the design of a nanocarrier that features a silica body with a surface defining multiple pores for molecule reception. This nanocarrier is coated with a lipid bilayer that securely seals the pores while incorporating a cargo-trapping agent within the phospholipid bilayer. This innovative design allows for stable interaction with desired cargo, such as drugs, enhancing the delivery system's effectiveness.
Career Highlights
Xiangsheng Liu is affiliated with the University of California, where he continues to advance research in nanotechnology and drug delivery systems. His work has garnered attention for its potential to revolutionize how medications are delivered in the medical field.
Collaborations
Liu collaborates with esteemed colleagues, including Huan Meng and Andre E Nel, to further enhance the impact of his research in the field of nanocarrier technology.
Conclusion
Xiangsheng Liu's innovative work in the development of silicasome nanocarriers represents a significant advancement in drug delivery systems. His contributions are poised to facilitate the approval and commercialization of new pharmaceutical technologies, ultimately benefiting the healthcare industry.